The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

THE NATIONAL ACADEMIES
National Research Council
Division on Policy and Global Affairs
Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology

*****

Congressional Briefings
Tuesday, October 7, 2003
2218 Rayburn House Office Bldg. -- 10:00 a.m.
and
428 Russell Senate Office Bldg. -- 1:00 p.m.

on

Biotechnology Research in an Age of Terrorism:
Confronting the "Dual Use" Dilemma

by

Gerald R. Fink, Member, Whitehead Institute for Biomedical Research and American Cancer Society Professor of Genetics, Massachusetts Institute of Technology, and Chair, Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, Division on Policy and Global Affairs, National Research Council, The National Academies

Ronald Atlas, Professor of Biology and Graduate Dean, University of Louisville and Member, Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, Division on Policy and Global Affairs, National Research Council, The National Academies

David Franz, Vice President, Chemical and Biological Defense Division, Southern Research Institute, Frederick, Md and Member, Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, Division on Policy and Global Affairs, National Research Council, The National Academies

This new report from the National Academies reviews and assesses the adequacy of current U.S. rules, regulations, institutional arrangements and processes that provide oversight of research on pathogens and potentially dangerous biotechnology research within government laboratories, universities, other research institutions, and industry. to prevent the destructive application of biotechnology research. It also recommends changes in these practices that could improve U.S. capacity to prevent the destructive application of biotechnology research while still enabling legitimate research to be conducted.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on October 8, 2003 and can be found, in its entirety, on the Web site of The National Academies Press.